SCHEMBL1700090

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL21633518	0.82	ALDH1A1 (0.37)	CA2CA1CA9CA3APLNR
	SCHEMBL23358220	0.82	PTGDR2 (0.37)	CA2CA1CA9PTGS2GAA
	SCHEMBL31028756	0.82	CA2 (0.47)	CA2CA1CA9CA3CA4
	SCHEMBL21633471	0.79	ALDH1A1 (0.38)	CA2CA1CA9GAA
	SCHEMBL31028699	0.78	PTGS2 (0.42)	CA2CA1CA9CA3CA4
	SCHEMBL31028653	0.78	CA2 (0.50)	CA2CA1CA9CA4CA12
	SCHEMBL21633463	0.78	GABRA2 (0.35)	CA2CA1CA9GAA
	SCHEMBL517787	0.76	ALDH1A1 (0.57)	CA2CA1CA9CA3GAA
	SCHEMBL31028676	0.71	PTGS2 (0.45)	CA2CA1CA9CA3CA4
	SCHEMBL18668405	0.71	CA2 (0.50)	CA2CA1CA9CA3CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.